Trials / Completed
CompletedNCT00746096
Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea
Phase 3, Placebo Controlled, Randomized, Double-blinded, Nonsteroidal Antiinflammatory Drug add-on Clinical Trial of Mono-phase Low Dose Oral Contraceptive Pill for Treatment of Primary Dysmenorrhea.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 115 (actual)
- Sponsor
- Nobelpharma · Industry
- Sex
- Female
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether combination oral contraceptive pill of norethindrone and ethinyl estradiol is effective in the treatment of primary dysmenorrhea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IKH-01 | ethinyl estradiol 0.035mg and norethisterone 1mg |
| DRUG | Placebo | Placebo for ethinyl estradiol 0.035mg and norethisterone 1mg |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2008-09-03
- Last updated
- 2025-03-06
- Results posted
- 2014-06-13
Source: ClinicalTrials.gov record NCT00746096. Inclusion in this directory is not an endorsement.